Back to Search
JOHANNES CZERNIN, MD
MD
Nuclear Medicine Physician
NPI: 1942245758IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nuclear Medicine PhysicianPrimary
Nuclear Medicine
Code: 207U00000X
A56351(CA)
Nuclear Medicine Technology Radiologic Technologist
Radiologic Technologist — Nuclear Medicine Technology
Code: 2471N0900X
A56351(CA)
CMS Specialties
PrimaryNUCLEAR MEDICINE
Education
OTHER
Class of 1983
Research & Publications (20)
Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow.
PMID 18716585·J Appl Clin Med Phys·2008
7-preclinical
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
PMID 17204723·J Nucl Med·2007
1-meta
FDG-PET in breast cancer: a different view of its clinical usefulness.
PMID 14538047·Mol Imaging Biol·2002
8-other
Positron emission tomography scanning: current and future applications.
PMID 11818465·Annu Rev Med·2002
6-review
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
PMID 16478857·Chest·2006
8-other
Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.
PMID 19372484·J Nucl Med·2009
7-preclinical
Utilization of positron emission tomography in the management of patients with sarcoma.
PMID 19412096·Curr Opin Oncol·2009
6-review
A supramolecular approach for preparation of size-controlled nanoparticles.
PMID 19425037·Angew Chem Int Ed Engl·2009
7-preclinical
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements.
PMID 19564622·Proc Natl Acad Sci U S A·2009
7-preclinical
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.
PMID 19351756·Clin Cancer Res·2009
8-other
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography.
PMID 19196993·Proc Natl Acad Sci U S A·2009
7-preclinical
Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib.
PMID 19318569·Cancer Res·2009
7-preclinical
Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma.
PMID 19015650·Nat Clin Pract Oncol·2009
5-case
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
PMID 19625624·Proc Natl Acad Sci U S A·2009
7-preclinical
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
PMID 18511228·Eur J Radiol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10833 LE CONTE AVE
LOS ANGELES, CA 90095 - Phone
- (310) 301-6800
Quick Facts
- NPI
- 1942245758
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile